Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
Resistance to therapy is a major obstacle to cancer treatment. It may exist from the beginning, or it may develop during therapy. The review focusses on oncolytic Newcastle disease virus (NDV) as a biological agent with potential to break therapy resistance. This avian virus combines, upon inoculati...
Main Authors: | Volker Schirrmacher, Stefaan van Gool, Wilfried Stuecker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/7/3/66 |
Similar Items
-
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
by: Volker Schirrmacher, et al.
Published: (2022-10-01) -
New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
by: Volker Schirrmacher
Published: (2020-03-01) -
Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
by: Volker Schirrmacher
Published: (2016-07-01) -
Multimodal cancer therapy involving oncolytic Newcastle Disease Virus, autologous immune cells and bispecific antibodies
by: Volker eSchirrmacher, et al.
Published: (2014-09-01) -
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
by: Noemi García-Romero, et al.
Published: (2020-06-01)